---
figid: PMC6540260__ijms-20-02194-g001
figlink: /pmc/articles/PMC6540260/figure/ijms-20-02194-f001/
number: Figure 1
caption: The role of T-cell suppression and immune checkpoint blockage in tumor and
  organ rejection. Activation of a T cell via 3-signal pathway by an antigen presenting
  cell (APC) is illustrated. The donor cells are rejected when the T cells are activated.
  Therefore, the immunosuppressants, which inhibit CD3 (Anti-CD3 mAB), calcineurin
  (Cyclosporine or Tacrolimus), CD80/86 (CTLA4-Ig), IL-2 signaling (Anti-CD25 mAB),
  JAK3 (JAK3 inhibitor), mammalian target of rapamycin (mTOR) (Sirolimus or Everolimus),
  and those interfere with the proliferative phase in the cell cycle (MPA, mycophenolate
  mofetil (MMF), azathioprine, and Fk778; not illustrated) are the key to successful
  post-transplantation outcomes. On the other hand, the employment of immune checkpoint
  inhibitors in transplant patients with cancer may increase the tumor killing while
  giving the chance for graft rejection. Therefore, fine-tuning the immunosuppressants
  and immune checkpoint inhibitors in transplanted patients with cancer is vital in
  achieving graft tolerance while treating cancer. APC, antigen presenting cell; CTLA4,
  cytotoxic T-lymphocyte-associated protein 4; IL-2, interleukin-2; IL-15, interleukin-15;
  JAK3, Janus kinase 3; PI3K, phosphoinositide 3-kinase; TCR, T-cell receptor; MHC
  I, major histocompatibility complex; mTOR, mammalian target of rapamycin; PD1, programmed
  cell death 1; PDL 1/2, programmed death-ligand 1/3.
pmcid: PMC6540260
papertitle: 'Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients
  with Advanced Cancer: A Double-Edged Sword?.'
reftext: Hung-Chih Lai, et al. Int J Mol Sci. 2019 May;20(9):2194.
pmc_ranked_result_index: '34617'
pathway_score: 0.8513598
filename: ijms-20-02194-g001.jpg
figtitle: T-cell suppression and immune checkpoint blockage in tumor and organ rejection
year: '2019'
organisms: Homo sapiens
ndex: 7042c4cd-df21-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6540260__ijms-20-02194-g001.html
  '@type': Dataset
  description: The role of T-cell suppression and immune checkpoint blockage in tumor
    and organ rejection. Activation of a T cell via 3-signal pathway by an antigen
    presenting cell (APC) is illustrated. The donor cells are rejected when the T
    cells are activated. Therefore, the immunosuppressants, which inhibit CD3 (Anti-CD3
    mAB), calcineurin (Cyclosporine or Tacrolimus), CD80/86 (CTLA4-Ig), IL-2 signaling
    (Anti-CD25 mAB), JAK3 (JAK3 inhibitor), mammalian target of rapamycin (mTOR) (Sirolimus
    or Everolimus), and those interfere with the proliferative phase in the cell cycle
    (MPA, mycophenolate mofetil (MMF), azathioprine, and Fk778; not illustrated) are
    the key to successful post-transplantation outcomes. On the other hand, the employment
    of immune checkpoint inhibitors in transplant patients with cancer may increase
    the tumor killing while giving the chance for graft rejection. Therefore, fine-tuning
    the immunosuppressants and immune checkpoint inhibitors in transplanted patients
    with cancer is vital in achieving graft tolerance while treating cancer. APC,
    antigen presenting cell; CTLA4, cytotoxic T-lymphocyte-associated protein 4; IL-2,
    interleukin-2; IL-15, interleukin-15; JAK3, Janus kinase 3; PI3K, phosphoinositide
    3-kinase; TCR, T-cell receptor; MHC I, major histocompatibility complex; mTOR,
    mammalian target of rapamycin; PD1, programmed cell death 1; PDL 1/2, programmed
    death-ligand 1/3.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CB
  - PIK3R4
  - PIK3R5
  - CD28
  - PPP3CC
  - PPP3R1
  - PPP3R2
  - IKBKG
  - CD86
  - CD80
  - CHUK
  - PPP3CA
  - PPP3CB
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK9
  - MAPK10
  - MAPK13
  - MAPK12
  - MTOR
  - IKBKB
  - IL15
  - APC
  - PIK3R6
  - CD3E
  - TRA
  - TRB
  - TRD
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - CD3G
  - PDCD1
  - CD274
  - PDCD1LG2
  - CD3D
  - MAPK1
  - MAPK14
  - CD247
  - TRG
  - JAK3
  - Cyclosporine
  - Tacrolimus
  - TCR
  - Sirolimus
  - Everolimus
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CC
  entrez: '5533'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R1
  entrez: '5534'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R2
  entrez: '5535'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: CD80/86
  symbol: CD86
  source: hgnc_symbol
  hgnc_symbol: CD86
  entrez: '942'
- word: CD80/86
  symbol: CD80
  source: hgnc_symbol
  hgnc_symbol: CD80
  entrez: '941'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CA
  entrez: '5530'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CB
  entrez: '5532'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IL-15
  symbol: IL-15
  source: hgnc_alias_symbol
  hgnc_symbol: IL15
  entrez: '3600'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: TCR/CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3E
  entrez: '916'
- word: TCR/CD3
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR/CD3
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR/CD3
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: TCR/CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3G
  entrez: '917'
- word: PD1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: PDL1/2
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: PDL1/2
  symbol: PD-L2
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1LG2
  entrez: '80380'
- word: TCR/CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3D
  entrez: '915'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: TCR/CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD247
  entrez: '919'
- word: TCR/CD3
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: JAK3
  symbol: JAK3
  source: hgnc_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
chemicals:
- word: Cyclosporine
  source: MESH
  identifier: D016572
- word: Tacrolimus
  source: MESH
  identifier: D016559
- word: TCR
  source: MESH
  identifier: D017260
- word: Sirolimus
  source: MESH
  identifier: D020123
- word: Everolimus
  source: MESH
  identifier: C107135
diseases: []
---
